Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease

The beneficial effects of drugs that act via nicotinic acetylcholine receptors (nAChRs) on Parkinson's disease (PD) symptomatology may explain the negative correlation between cigarette smoking and risk of this neurological condition. Varenicline, an α4β2 nAChR partial agonist approved for smok...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro-Carvalho, A., Leal-Rocha, P.H., Isnardo-Fernandes, J., Araújo, U.C., Abreu-Villaça, Y., Filgueiras, C.C., Manhães, A.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647902/
https://www.ncbi.nlm.nih.gov/pubmed/34878065
http://dx.doi.org/10.1590/1414-431X2021e11679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647902/
https://www.ncbi.nlm.nih.gov/pubmed/34878065
http://dx.doi.org/10.1590/1414-431X2021e11679

Ejemplares similares